| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88381582 | FILING DATE | 04/11/2019 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | TANNER, MICHAEL R |
L.O. ASSIGNED | 119 |
PUB INFORMATION |
|||
| RUN DATE | 12/04/2019 | ||
| PUB DATE | 07/23/2019 | ||
| STATUS | 688-NOTICE OF ALLOWANCE - ISSUED | ||
| STATUS DATE | 09/17/2019 | ||
| LITERAL MARK ELEMENT | NAMVONA | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | NAMVONA |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Glaxo Group Limited |
| ADDRESS | 980 Great West Road Brentford, Middlesex, TW89GS |
| ENTITY | 99-private company limited by shares (prc) |
| CITIZENSHIP | GB2 |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 12/03/2019 | APET | A | ASSIGNED TO PETITION STAFF | 013 |
| 10/01/2019 | 44EP | I | 44(e) PETITION - RECEIVED | 012 |
| 12/03/2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 011 |
| 11/14/2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 010 |
| 10/01/2019 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | 009 |
| 09/17/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 008 |
| 07/23/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 007 |
| 07/23/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 006 |
| 07/03/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 005 |
| 06/15/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 004 |
| 06/10/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 05/01/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 04/15/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Merilee J. Arevalo |
| CORRESPONDENCE ADDRESS | Merilee J. Arevalo GSK LBP, 5.5A 5 MOORE DRIVE RESEARCH TRIANGLE PARK NC 27709-3398 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Glaxo Group Limited |
| ADDRESS | 980 Great West Road Brentford, Middlesex, TW89GS |
| ENTITY | 99-private company limited by shares (prc) |
| CITIZENSHIP | GB2 |